Toll-Like Receptors in Dermatology

Dermatologic Clinics

Volumn 25, Issue 4, 2007, Pages 531-540

  Mempel, Martin ^a   Kalali, Behnam Naderi ^a   Ollert, Markus ^a   Ring, Johannes ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; RESIQUIMOD; TOLL LIKE RECEPTOR;

ACNE VULGARIS; ATOPIC DERMATITIS; BORRELIA INFECTION; EPIDERMIS; HUMAN; IMMUNE RESPONSE; LEPROSY; LUPUS ERYTHEMATOSUS; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; SKIN CANCER; SKIN CELL; SKIN DISEASE; SYPHILIS; VERRUCA VULGARIS;

DERMATOLOGIC AGENTS; EPIDERMIS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIGANDS; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; SKIN DISEASES; TOLL-LIKE RECEPTORS;

EID: 34548815890     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.det.2007.06.014     Document Type: Review

References (86)

1. Akira S., Uematsu S., and Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (2006) 783-801
2. Kawai T., and Akira S. TLR signaling. Cell Death Differ 13 (2006) 816-825
3. Anderson K.V., Jurgens G., and Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell 42 (1985) 779-789
4. Anderson K.V., and Nusslein-Volhard C. Information for the dorsal-ventral pattern of the Drosophila embryo is stored as maternal mRNA. Nature 311 (1984) 223-227
5. Cohen B. Nobel committee rewards pioneers of development studies in fruitflies. Nature 377 (1995) 465
6. Medzhitov R., Preston-Hurlburt P., and Janeway Jr. C.A. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388 (1997) 394-397
7. Kawai T., and Akira S. Pathogen recognition with Toll-like receptors. Curr Opin Immunol 17 (2005) 338-344
8. Kurt-Jones E.A., Popova L., Kwinn L., et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat Immunol 1 (2000) 398-401
9. Beg A.A. Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses. Trends Immunol 23 (2002) 509-512
10. Biragyn A., Ruffini P.A., Leifer C.A., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science 298 (2002) 1025-1029
11. Okamura Y., Watari M., Jerud E.S., et al. The extra domain A of fibronectin activates Toll-like receptor 4. J Biol Chem 276 (2001) 10229-10233
12. Schwandner R., Dziarski R., Wesche H., et al. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by toll-like receptor 2. J Biol Chem 274 (1999) 17406-17409
13. Gilleron M., Quesniaux V.F., and Puzo G. Acylation state of the phosphatidylinositol hexamannosides from Mycobacterium bovis bacillus Calmette Guerin and mycobacterium tuberculosis H37Rv and its implication in Toll-like receptor response. J Biol Chem 278 (2003) 29880-29889
14. Bieback K., Lien E., Klagge I.M., et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 76 (2002) 8729-8736
15. Lopez M., Sly L.M., Luu Y., et al. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2. J Immunol 170 (2003) 2409-2416
16. Bulut Y., Faure E., Thomas L., et al. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J Immunol 167 (2001) 987-994
17. Kang S.S., Kauls L.S., and Gaspari A.A. Toll-like receptors: applications to dermatologic disease. J Am Acad Dermatol 54 (2006) 951-983 [Quiz: 83-6]
18. Hajjar A.M., O'Mahony D.S., Ozinsky A., et al. Cutting edge: functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J Immunol 166 (2001) 15-19
19. Sato M., Sano H., Iwaki D., et al. Direct binding of Toll-like receptor 2 to zymosan, and zymosan-induced NF-kappa B activation and TNF-alpha secretion are down-regulated by lung collectin surfactant protein A. J Immunol 171 (2003) 417-425
20. Hayashi F., Smith K.D., Ozinsky A., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 410 (2001) 1099-1103
21. Mizel S.B., Honko A.N., Moors M.A., et al. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes. J Immunol 170 (2003) 6217-6223
22. Wagner H. The immunobiology of the TLR9 subfamily. Trends Immunol 25 (2004) 381-386
23. Alexopoulou L., Holt A.C., Medzhitov R., et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001) 732-738
24. Diebold S.S., Kaisho T., Hemmi H., et al. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004) 1529-1531
25. Heil F., Hemmi H., Hochrein H., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004) 1526-1529
26. Hemmi H., Kaisho T., Takeuchi O., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol 3 (2002) 196-200
27. Hemmi H., Takeuchi O., Kawai T., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000) 740-745
28. Schiller M., Metze D., Luger T.A., et al. Immune response modifiers-mode of action. Exp Dermatol 15 (2006) 331-341
29. Hasan U., Chaffois C., Gaillard C., et al. Human TLR10 is a functional receptor, expressed by B cells and plasmacytoid dendritic cells, which activates gene transcription through MyD88. J Immunol 174 (2005) 2942-2950
30. Bowie A., and O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal generators for pro-inflammatory interleukins and microbial products. J Leukoc Biol 67 (2000) 508-514
31. Carty M., Goodbody R., Schroder M., et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol 7 (2006) 1074-1081
32. Hashimoto C., Hudson K.L., and Anderson K.V. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52 (1988) 269-279
33. Yamamoto M., Sato S., Hemmi H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 301 (2003) 640-643
34. Fitzgerald K.A., Rowe D.C., Barnes B.J., et al. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 198 (2003) 1043-1055
35. Fitzgerald K.A., McWhirter S.M., Faia K.L., et al. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4 (2003) 491-496
36. Blander J.M., and Medzhitov R. Regulation of phagosome maturation by signals from toll-like receptors. Science 304 (2004) 1014-1018
37. Underhill D.M., Ozinsky A., Hajjar A.M., et al. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401 (1999) 811-815
38. Blander J.M., and Medzhitov R. Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 440 (2006) 808-812
39. Michelsen K.S., Aicher A., Mohaupt M., et al. The role of toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 276 (2001) 25680-25686
40. Tsuji S., Matsumoto M., Takeuchi O., et al. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of toll-like receptors. Infect Immun 68 (2000) 6883-6890
41. Heit A., Maurer T., Hochrein H., et al. Cutting edge: Toll-like receptor 9 expression is not required for CpG DNA-aided cross-presentation of DNA-conjugated antigens but essential for cross-priming of CD8 T cells. J Immunol 170 (2003) 2802-2805
42. Zaks K., Jordan M., Guth A., et al. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol 176 (2006) 7335-7345
43. Becker M.N., Diamond G., Verghese M.W., et al. CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J Biol Chem 275 (2000) 29731-29736
44. Hertz C.J., Wu Q., Porter E.M., et al. Activation of Toll-like receptor 2 on human tracheobronchial epithelial cells induces the antimicrobial peptide human beta defensin-2. J Immunol 171 (2003) 6820-6826
45. Liu P.T., Stenger S., Li H., et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 311 (2006) 1770-1773
46. Dabbagh K., and Lewis D.B. Toll-like receptors and T-helper-1/T-helper-2 responses. Curr Opin Infect Dis 16 (2003) 199-204
47. Into T., Kiura K., Yasuda M., et al. Stimulation of human Toll-like receptor (TLR) 2 and TLR6 with membrane lipoproteins of Mycoplasma fermentans induces apoptotic cell death after NF-kappa B activation. Cell Microbiol 6 (2004) 187-199
48. Köllisch G., Kalali B.N., Voelcker V., et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 114 (2005) 531-541
49. Mempel M., Voelcker V., Köllisch G., et al. Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol 121 (2003) 1389-1396
50. Miller L.S., Sorensen O.E., Liu P.T., et al. TGF-alpha regulates TLR expression and function on epidermal keratinocytes. J Immunol 174 (2005) 6137-6143
51. Pivarcsi A., Bodai L., Rethi B., et al. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol 15 (2003) 721-730
52. Renn C.N., Sanchez D.J., Ochoa M.T., et al. TLR activation of Langerhans cell-like dendritic cells triggers an antiviral immune response. J Immunol 177 (2006) 298-305
53. Terhorst D., Kalali B.N., Weidinger S., et al. Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands. Clin Exp Allergy 37 (2007) 381-390
54. Lebre M.C., Antons J.C., Kalinski P., et al. Double-stranded RNA-exposed human keratinocytes promote Th1 responses by inducing a Type-1 polarized phenotype in dendritic cells: role of keratinocyte-derived tumor necrosis factor alpha, type I interferons, and interleukin-18. J Invest Dermatol 120 (2003) 990-997
55. Voelcker V., Gebhardt C., Averbeck M., et al. Small fragments of hyaluronic acid (HA) induce metalloprotease- and cytokine upregulation in human melanoma cells. [abstract]. J Invest Dermatol 126 (2006) S30
56. Krutzik S.R., and Modlin R.L. The role of Toll-like receptors in combating mycobacteria. Semin Immunol 16 (2004) 35-41
57. Krutzik S.R., Ochoa M.T., Sieling P.A., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 9 (2003) 525-532
58. McInturff J.E., Modlin R.L., and Kim J. The role of toll-like receptors in the pathogenesis and treatment of dermatological disease. J Invest Dermatol 125 (2005) 1-8
59. Oliveira R.B., Ochoa M.T., Sieling P.A., et al. Expression of Toll-like receptor 2 on human Schwann cells: a mechanism of nerve damage in leprosy. Infect Immun 71 (2003) 1427-1433
60. Vowels B.R., Yang S., and Leyden J.J. Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne. Infect Immun 63 (1995) 3158-3165
61. Kim J., Ochoa M.T., Krutzik S.R., et al. Activation of toll-like receptor 2 in acne triggers inflammatory cytokine responses. J Immunol 169 (2002) 1535-1541
62. Barrat F.J., Meeker T., Gregorio J., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J Exp Med 202 (2005) 1131-1139
63. Boule M.W., Broughton C., Mackay F., et al. Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes. J Exp Med 199 (2004) 1631-1640
64. Ding C., Wang L., Al-Ghawi H., et al. Toll-like receptor engagement stimulates anti-snRNP autoreactive B cells for activation. Eur J Immunol 36 (2006) 2013-2024
65. Ehlers M., Fukuyama H., McGaha T.L., et al. TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE. J Exp Med 203 (2006) 553-561
66. Lau C.M., Broughton C., Tabor A.S., et al. RNA-associated autoantigens activate B cells by combined B cell antigen receptor/Toll-like receptor 7 engagement. J Exp Med 202 (2005) 1171-1177
67. Savarese E., Chae O.W., Trowitzsch S., et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107 (2006) 3229-3234
68. Rahman A.H., and Eisenberg R.A. The role of toll-like receptors in systemic lupus erythematosus. Springer Semin Immunopathol 28 (2006) 131-143
69. Baker B.S., Ovigne J.M., Powles A.V., et al. Normal keratinocytes express Toll-like receptors (TLRs) 1, 2 and 5: modulation of TLR expression in chronic plaque psoriasis. Br J Dermatol 148 (2003) 670-679
70. Ong P.Y., Ohtake T., Brandt C., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
71. Schroder N.W., Heine H., Alexander C., et al. Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses. J Immunol 173 (2004) 2683-2691
72. Cabral E.S., Gelderblom H., Hornung R.L., et al. Borrelia burgdorferi lipoprotein-mediated TLR2 stimulation causes the down-regulation of TLR5 in human monocytes. J Infect Dis 193 (2006) 849-859
73. Behera A.K., Hildebrand E., Uematsu S., et al. Identification of a TLR-independent pathway for Borrelia burgdorferi-induced expression of matrix metalloproteinases and inflammatory mediators through binding to integrin alpha 3 beta 1. J Immunol 177 (2006) 657-664
74. Bouis D.A., Popova T.G., Takashima A., et al. Dendritic cells phagocytose and are activated by Treponema pallidum. Infect Immun 69 (2001) 518-528
75. Ring J., Darsow U., Jacob T., et al. Eczema and dermatitis. Allergy & Clinical Immunology International - Journal of the World Allergy Organization 17 (2005) 19-25
76. Eder W., Klimecki W., Yu L., et al. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 113 (2004) 482-488
77. Weidinger S., Novak N., Klopp N., et al. Lack of association between Toll-like receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 118 (2006) 277-279
78. Lauener R.P., Birchler T., Adamski J., et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 360 (2002) 465-466
79. In: Ring J., Przybilla B., and Ruzicka T. (Eds). Handbook of atopic eczema (2006), Springer, Berlin, New York
80. Mothes N., Heinzkill M., Drachenberg K.J., et al. Allergen-specific immunotherapy with a monophosphoryl lipid A-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 33 (2003) 1198-1208
81. Creticos P.S., Schroeder J.T., Hamilton R.G., et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 355 (2006) 1445-1455
82. Kodner C.M., and Nasraty S. Management of genital warts. Am Fam Physician 70 (2004) 2335-2342
83. Schon M.P., and Schon M. Immune modulation and apoptosis induction: two sides of the antitumoral activity of imiquimod. Apoptosis 9 (2004) 291-298
84. Wille-Reece U., Wu C.Y., Flynn B.J., et al. Immunization with HIV-1 Gag protein conjugated to a TLR7/8 agonist results in the generation of HIV-1 Gag-specific Th1 and CD8+ T cell responses. J Immunol 174 (2005) 7676-7683
85. Kalali N.B., Köllisch G., Bauer S., et al. Innate immune response of human keratinocytes to doubled stranded RNA (dsRNA). J Invest Dermatol 126 (2006) S57 [abstract]
86. Schon M.P., Schon M., and Klotz K.N. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol 126 (2006) 1338-1347